NCBI Taxonomy: 2895626

Melochia pyramidata (ncbi_taxid: 2895626)

found 26 associated metabolites at species taxonomy rank level.

Ancestor: Melochia

Child Taxonomies: none taxonomy data.

Choline

(2-hydroxyethyl)trimethylazanium

[C5H14NO]+ (104.1075)


Choline is a basic constituent of lecithin that is found in many plants and animal organs. It is important as a precursor of acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism. Choline is now considered to be an essential vitamin. While humans can synthesize small amounts (by converting phosphatidylethanolamine to phosphatidylcholine), it must be consumed in the diet to maintain health. Required levels are between 425 mg/day (female) and 550 mg/day (male). Milk, eggs, liver, and peanuts are especially rich in choline. Most choline is found in phospholipids, namely phosphatidylcholine or lecithin. Choline can be oxidized to form betaine, which is a methyl source for many reactions (i.e. conversion of homocysteine into methionine). Lack of sufficient amounts of choline in the diet can lead to a fatty liver condition and general liver damage. This arises from the lack of VLDL, which is necessary to transport fats away from the liver. Choline deficiency also leads to elevated serum levels of alanine amino transferase and is associated with increased incidence of liver cancer. Nutritional supplement. Occurs free and combined in many animal and vegetable foods with highest concentrations found in egg yolk, meat, fish, milk, cereaks and legumes Choline. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=62-49-7 (retrieved 2024-06-29) (CAS RN: 62-49-7). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

   
   
   
   

Choline

Choline

[C5H14NO]+ (104.1075)


D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D008082 - Lipotropic Agents D002491 - Central Nervous System Agents > D018697 - Nootropic Agents D009676 - Noxae > D000963 - Antimetabolites D005765 - Gastrointestinal Agents

   

methyluracil

1-METHYLURACIL

C5H6N2O2 (126.0429)


A pyrimidone that is uracil with a methyl group substituent at position 1.

   

Choline

Choline chloride

[C5H14NO]+ (104.1075)


MS2 deconvoluted using MS2Dec from all ion fragmentation data, MetaboLights identifier MTBLS1040; OEYIOHPDSNJKLS_STSL_0152_Choline_0125fmol_180430_S2_LC02_MS02_80; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. MS2 deconvoluted using CorrDec from all ion fragmentation data, MetaboLights identifier MTBLS1040; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D008082 - Lipotropic Agents D002491 - Central Nervous System Agents > D018697 - Nootropic Agents IPB_RECORD: 922; CONFIDENCE confident structure D009676 - Noxae > D000963 - Antimetabolites D005765 - Gastrointestinal Agents

   
   

Choline

Choline Hydroxide

C5H14NO+ (104.1075)


A choline that is the parent compound of the cholines class, consisting of ethanolamine having three methyl substituents attached to the amino function. D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D008082 - Lipotropic Agents D002491 - Central Nervous System Agents > D018697 - Nootropic Agents D009676 - Noxae > D000963 - Antimetabolites D005765 - Gastrointestinal Agents

   
   

3-methoxy-2-methyl-6-(11-oxododecyl)-1h-pyridin-4-one

3-methoxy-2-methyl-6-(11-oxododecyl)-1h-pyridin-4-one

C19H31NO3 (321.2304)


   

6-[(11r)-11-hydroxydodecyl]-3-methoxy-2-methyl-1h-pyridin-4-one

6-[(11r)-11-hydroxydodecyl]-3-methoxy-2-methyl-1h-pyridin-4-one

C19H33NO3 (323.246)


   

(2s)-n-[(3r,4s,7s,10e)-5,8-dihydroxy-3-isopropyl-7-(2-methylpropyl)-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidic acid

(2s)-n-[(3r,4s,7s,10e)-5,8-dihydroxy-3-isopropyl-7-(2-methylpropyl)-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidic acid

C31H42N4O4 (534.3206)


   

n-[5,8-dihydroxy-7-(2-methylpropyl)-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-methylbutanimidic acid

n-[5,8-dihydroxy-7-(2-methylpropyl)-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-methylbutanimidic acid

C30H40N4O4 (520.3049)


   

(2r)-n-[(3r,4r,7r,10z)-7-benzyl-5,8-dihydroxy-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-1-[(2s)-2-(dimethylamino)-3-phenylpropanoyl]pyrrolidine-2-carboximidic acid

(2r)-n-[(3r,4r,7r,10z)-7-benzyl-5,8-dihydroxy-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-1-[(2s)-2-(dimethylamino)-3-phenylpropanoyl]pyrrolidine-2-carboximidic acid

C42H45N5O5 (699.3421)


   

(2s)-n-[(3r,4s,7s,10z)-7-benzyl-5,8-dihydroxy-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-1-[(2s)-2-(dimethylamino)-3-phenylpropanoyl]pyrrolidine-2-carboximidic acid

(2s)-n-[(3r,4s,7s,10z)-7-benzyl-5,8-dihydroxy-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-1-[(2s)-2-(dimethylamino)-3-phenylpropanoyl]pyrrolidine-2-carboximidic acid

C42H45N5O5 (699.3421)


   

(2s,3r)-n-[(3r,4s,7s,10z)-5,8-dihydroxy-7-(2-methylpropyl)-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-methylpentanimidic acid

(2s,3r)-n-[(3r,4s,7s,10z)-5,8-dihydroxy-7-(2-methylpropyl)-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-methylpentanimidic acid

C31H42N4O4 (534.3206)


   

3-methoxy-2-methyl-6-(11-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}dodecyl)-1h-pyridin-4-one

3-methoxy-2-methyl-6-(11-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}dodecyl)-1h-pyridin-4-one

C25H43NO8 (485.2989)


   

4-hydroxy-1-methylpyrimidin-2-one

4-hydroxy-1-methylpyrimidin-2-one

C5H6N2O2 (126.0429)


   

3-methoxy-2-methyl-6-[(11s)-11-{[(2s,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}dodecyl]-1h-pyridin-4-one

3-methoxy-2-methyl-6-[(11s)-11-{[(2s,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}dodecyl]-1h-pyridin-4-one

C25H43NO8 (485.2989)


   

(2s)-n-[(3s,4r,7r,10z)-5,8-dihydroxy-3-isopropyl-7-(2-methylpropyl)-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidic acid

(2s)-n-[(3s,4r,7r,10z)-5,8-dihydroxy-3-isopropyl-7-(2-methylpropyl)-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidic acid

C31H42N4O4 (534.3206)


   

(2s)-n-[(3s,4r,7r,10z)-5,8-dihydroxy-7-(2-methylpropyl)-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-methylbutanimidic acid

(2s)-n-[(3s,4r,7r,10z)-5,8-dihydroxy-7-(2-methylpropyl)-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-methylbutanimidic acid

C30H40N4O4 (520.3049)


   

n-[5,8-dihydroxy-3-isopropyl-7-(2-methylpropyl)-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidic acid

n-[5,8-dihydroxy-3-isopropyl-7-(2-methylpropyl)-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidic acid

C31H42N4O4 (534.3206)


   

2-[(11s)-11-hydroxydodecyl]-3-methoxy-6-methyl-1h-pyridin-4-one

2-[(11s)-11-hydroxydodecyl]-3-methoxy-6-methyl-1h-pyridin-4-one

C19H33NO3 (323.246)


   

2-(11-hydroxydodecyl)-3-methoxy-6-methyl-1h-pyridin-4-one

2-(11-hydroxydodecyl)-3-methoxy-6-methyl-1h-pyridin-4-one

C19H33NO3 (323.246)


   

n-{7-benzyl-5,8-dihydroxy-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl}-1-[2-(dimethylamino)-3-phenylpropanoyl]pyrrolidine-2-carboximidic acid

n-{7-benzyl-5,8-dihydroxy-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl}-1-[2-(dimethylamino)-3-phenylpropanoyl]pyrrolidine-2-carboximidic acid

C42H45N5O5 (699.3421)